Literature DB >> 22272391

India reports cases of totally drug-resistant tuberculosis.

Samuel Loewenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22272391     DOI： 10.1016/s0140-6736(12)60085-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  19 in total

1.  Design and synthesis of novel antimicrobials with activity against Gram-positive bacteria and mycobacterial species, including M. tuberculosis.

Authors:  V V N Phani Babu Tiruveedhula; Christopher M Witzigmann; Ranjit Verma; M Shahjahan Kabir; Marc Rott; William R Schwan; Sara Medina-Bielski; Michelle Lane; William Close; Rebecca L Polanowski; David Sherman; Aaron Monte; Jeffrey R Deschamps; James M Cook
Journal:  Bioorg Med Chem       Date:  2013-10-21       Impact factor: 3.641

2.  Inactivation of the Mycobacterium tuberculosis antigen 85 complex by covalent, allosteric inhibitors.

Authors:  Lorenza Favrot; Daniel H Lajiness; Donald R Ronning
Journal:  J Biol Chem       Date:  2014-07-14       Impact factor: 5.157

3.  Encounters with an old foe: Childhood tuberculosis in Canada.

Authors:  Ian Kitai; Shaun K Morris
Journal:  Paediatr Child Health       Date:  2014-02       Impact factor: 2.253

4.  Exploring Covalent Allosteric Inhibition of Antigen 85C from Mycobacterium tuberculosis by Ebselen Derivatives.

Authors:  Christopher M Goins; Steven Dajnowicz; Sandeep Thanna; Steven J Sucheck; Jerry M Parks; Donald R Ronning
Journal:  ACS Infect Dis       Date:  2017-03-21       Impact factor: 5.084

Review 5.  Pipeline of drugs for related diseases: tuberculosis.

Authors:  Kelly E Dooley; Eric L Nuermberger; Andreas H Diacon
Journal:  Curr Opin HIV AIDS       Date:  2013-11       Impact factor: 4.283

6.  Efficacy of nitazoxanide against clinical isolates of Mycobacterium tuberculosis.

Authors:  Kristina Shigyo; Oksana Ocheretina; Yves Mary Merveille; Warren D Johnson; Jean William Pape; Carl F Nathan; Daniel W Fitzgerald
Journal:  Antimicrob Agents Chemother       Date:  2013-03-18       Impact factor: 5.191

Review 7.  Challenges in the clinical assessment of novel tuberculosis drugs.

Authors:  Kelly E Dooley; Patrick P J Phillips; Payam Nahid; Michael Hoelscher
Journal:  Adv Drug Deliv Rev       Date:  2016-01-28       Impact factor: 15.470

8.  Tetrahydroisoquinolines affect the whole-cell phenotype of Mycobacterium tuberculosis by inhibiting the ATP-dependent MurE ligase.

Authors:  Juan D Guzman; Thomas Pesnot; Diana A Barrera; Heledd M Davies; Eleanor McMahon; Dimitrios Evangelopoulos; Parisa N Mortazavi; Tulika Munshi; Arundhati Maitra; Eleanor D Lamming; Richard Angell; Markus C Gershater; Joanna M Redmond; Deborah Needham; John M Ward; Luis E Cuca; Helen C Hailes; Sanjib Bhakta
Journal:  J Antimicrob Chemother       Date:  2015-02-04       Impact factor: 5.790

Review 9.  Revisiting public health challenges in the new millennium.

Authors:  Ts Anish; Pr Sreelakshmi
Journal:  Ann Med Health Sci Res       Date:  2013-07

10.  Mechanism of inhibition of Mycobacterium tuberculosis antigen 85 by ebselen.

Authors:  Lorenza Favrot; Anna E Grzegorzewicz; Daniel H Lajiness; Rachel K Marvin; Julie Boucau; Dragan Isailovic; Mary Jackson; Donald R Ronning
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.